FDA Clearance Tracker · K192207
Trevo NXT ProVue Retriever
Last checked: Nov 19, 2026Latest source record: Nov 22, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Nov 22, 2019
Substantially Equivalent
Time to decision
100 days
Received Aug 14, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K192207
- Device name
- Trevo NXT ProVue Retriever
- Applicant
- Stryker
- Applicant location
- Fremont, CA
- Received
- Aug 14, 2019
- Decided
- Nov 22, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5600
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code POL. The earliest in FDA's data is DEN150049, decided Sep 2, 2016.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K192207
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Stryker
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262500 · Decided Nov 4, 2026 · 107 days after receipt
Device type: Gown, Non-Sterile, Non-Isolation, Intended To Provide Moderate Or High Barrier Protection (QPC) · General & Plastic Surgery
K262386 · Decided Oct 20, 2026 · 99 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
K261649 · Decided Oct 9, 2026 · 143 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.